Literature DB >> 7160051

Effects of polysorbate 80 on the absorption and distribution of oral methotrexate (MTX) in mice.

M N Azmin, J F Stuart, K C Calman, A T Florence.   

Abstract

This study is part of a programme of work aimed at improving the bioavailability of oral methotrexate (MTX). In preliminary experiments no significant effect of non-ionic surfactant polysorbate 80 (Tween 80) on absorption of 0.5 mg MTX X kg-1 in NMRI mice was observed except when the drug was given together with 6% polysorbate 80 in solution. Absorption from a higher dose of 3 mg MTX X kg-1 was increased when the drug was administered with 2% or 6% polysorbate 80. Plasma MTX measurements confirmed the significantly higher levels of MTX with 6% polysorbate 80 PO. In subsequent experiments, when Porton mice were used and 4 mg MTX X kg-1 was administered PO, higher plasma and brain levels of MTX were measured in animals given the drug with 6% polysorbate 80, suggesting the enhancement of MTX uptake by this non-ionic surfactant. Although the amount of MTX in the liver and kidney of mice given MTX with polysorbate 80 were not significantly different from the amounts in mice given MTX alone, the lower observed levels suggested that polysorbate 80 perhaps facilitates the elimination of the drug from these organs. The amount of plasma MTX in mice measured 1 h after oral administration of various MTX doses in the presence of 6% polysorbate 80 were significantly higher than the levels in mice given the drug without surfactant, but the significantly higher amounts of MTX in the brain were only observed following the doses of 2 and 6 mg MTX X kg-1.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7160051     DOI: 10.1007/bf00257745

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  18 in total

1.  Emptying effect on the gall bladder of Tween 80 and some related compounds.

Authors:  L ANDREN; G THEANDER
Journal:  Gastroenterology       Date:  1961-05       Impact factor: 22.682

Review 2.  THE PHENOTHIAZINETRANQUILIZERS: BIOCHEMICAL AND BIOPHYSICAL ACTIONS.

Authors:  P S GUTH; M A SPIRTES
Journal:  Int Rev Neurobiol       Date:  1964       Impact factor: 3.230

3.  A pH-dependent, carrier-mediated transport system for the folate analog, amethopterin, in rat jejunum.

Authors:  W B Strum
Journal:  J Pharmacol Exp Ther       Date:  1977-12       Impact factor: 4.030

4.  Effect of route of administration and effusions on methotrexate pharmacokinetics.

Authors:  S H Wan; D H Huffman; D L Azarnoff; R Stephens; B Hoogstraten
Journal:  Cancer Res       Date:  1974-12       Impact factor: 12.701

5.  Bioavailability of methotrexate: implications for clinical use.

Authors:  J F Stuart; K C Calman; J Watters; J Paxton; B Whiting; J R Lawrence; W H Steele; J G McVie
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

6.  Tween 80 increases plasma adriamycin concentrations in mice by an apparent reduction of plasma volume.

Authors:  S D Harrison; A M Cusic; S M McAfee
Journal:  Eur J Cancer       Date:  1981-04       Impact factor: 9.162

Review 7.  Sorption promotors in biopharmaceutics.

Authors:  W A Ritschel
Journal:  Angew Chem Int Ed Engl       Date:  1969-10       Impact factor: 15.336

8.  Basic experiments on oral administration of 5-fluorouracil emulsion as adjuvant chemotherapy to surgical treatment for gastric cancer.

Authors:  S Watanabe; E Nakao; K Cho; B Nishioka; Y Fujita; T Takahashi; S Majima
Journal:  Jpn J Surg       Date:  1978-03

9.  Comparison of intravenous and oral high-dose methotrexate in treatment of solid tumours.

Authors:  N Christophidis; F J Vajda; I Lucas; W J Moon; W J Louis
Journal:  Br Med J       Date:  1979-02-03

10.  Limited penetration of methotrexate into human osteosarcoma spheroids as a proposed model for solid tumor resistance to adjuvant chemotherapy.

Authors:  G W West; R Weichselbaum; J B Little
Journal:  Cancer Res       Date:  1980-10       Impact factor: 12.701

View more
  5 in total

Review 1.  Role of formulation vehicles in taxane pharmacology.

Authors:  L van Zuylen; J Verweij; A Sparreboom
Journal:  Invest New Drugs       Date:  2001-05       Impact factor: 3.850

2.  Delivery of loperamide across the blood-brain barrier with polysorbate 80-coated polybutylcyanoacrylate nanoparticles.

Authors:  R N Alyautdin; V E Petrov; K Langer; A Berthold; D A Kharkevich; J Kreuter
Journal:  Pharm Res       Date:  1997-03       Impact factor: 4.200

Review 3.  Pharmacological effects of formulation vehicles : implications for cancer chemotherapy.

Authors:  Albert J ten Tije; Jaap Verweij; Walter J Loos; Alex Sparreboom
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

4.  The distribution and elimination of methotrexate in mouse blood and brain after concurrent administration of polysorbate 80.

Authors:  M N Azmin; J F Stuart; A T Florence
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

5.  Bioequivalence of HTX-019 (aprepitant IV) and fosaprepitant in healthy subjects: a Phase I, open-label, randomized, two-way crossover evaluation.

Authors:  Tom Ottoboni; Mary Rose Keller; Matt Cravets; Neil Clendeninn; Barry Quart
Journal:  Drug Des Devel Ther       Date:  2018-03-01       Impact factor: 4.162

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.